SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmuLogic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Getman who wrote (4)9/16/1996 11:25:00 PM
From: David Bleich   of 23
 
Paul:

Great article in Health Journal of WSJ today on allergy suffers. This market is huge and antihistamines just do't do the trick for most allergy sufferers. When IMUL pulls through with its Ragweed vaccine the dollars should just roll in. No real competition except for one biotech I remeber vaguely working on an IgE vaccine. This approach is not as specific as IMUL peptide vaccine and therefore potentially could have unforseen side effects. It would have been nice if the article mentioned IMUL, but that will come in due time.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News